337 related articles for article (PubMed ID: 29408401)
1. Modeling of FMISO [F
Asgari H; Soltani M; Sefidgar M
Microvasc Res; 2018 Jul; 118():20-30. PubMed ID: 29408401
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal distribution modeling of PET tracer uptake in solid tumors.
Soltani M; Sefidgar M; Bazmara H; Casey ME; Subramaniam RM; Wahl RL; Rahmim A
Ann Nucl Med; 2017 Feb; 31(2):109-124. PubMed ID: 27921285
[TBL] [Abstract][Full Text] [Related]
3. A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data.
Kelly CJ; Brady M
Phys Med Biol; 2006 Nov; 51(22):5859-73. PubMed ID: 17068369
[TBL] [Abstract][Full Text] [Related]
4. The role of necrosis, acute hypoxia and chronic hypoxia in
Warren DR; Partridge M
Phys Med Biol; 2016 Dec; 61(24):8596-8624. PubMed ID: 27880734
[TBL] [Abstract][Full Text] [Related]
5. Molecular Imaging of Tumor Hypoxia: Existing Problems and Their Potential Model-Based Solutions.
Shi K; Ziegler SI; Vaupel P
Adv Exp Med Biol; 2016; 923():87-93. PubMed ID: 27526129
[TBL] [Abstract][Full Text] [Related]
6. Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Zips D; Thorwarth D
Acta Oncol; 2013 Oct; 52(7):1308-13. PubMed ID: 23984808
[TBL] [Abstract][Full Text] [Related]
7. Matching the reaction-diffusion simulation to dynamic [
Shi K; Bayer C; Gaertner FC; Astner ST; Wilkens JJ; Nüsslin F; Vaupel P; Ziegler SI
Physiol Meas; 2017 Feb; 38(2):188-204. PubMed ID: 28055983
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [
Kelada OJ; Rockwell S; Zheng MQ; Huang Y; Liu Y; Booth CJ; Decker RH; Oelfke U; Carson RE; Carlson DJ
Mol Imaging Biol; 2017 Dec; 19(6):893-902. PubMed ID: 28409339
[TBL] [Abstract][Full Text] [Related]
9. Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia.
Piert M; Machulla H; Becker G; Stahlschmidt A; Patt M; Aldinger P; Dissmann PD; Fischer H; Bares R; Becker HD; Lauchart W
Eur J Nucl Med; 1999 Feb; 26(2):95-109. PubMed ID: 9933343
[TBL] [Abstract][Full Text] [Related]
10. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.
Casciari JJ; Graham MM; Rasey JS
Med Phys; 1995 Jul; 22(7):1127-39. PubMed ID: 7565388
[TBL] [Abstract][Full Text] [Related]
11. Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia--a simulation study.
Wack LJ; Mönnich D; van Elmpt W; Zegers CM; Troost EG; Zips D; Thorwarth D
Acta Oncol; 2015; 54(9):1370-7. PubMed ID: 26203928
[TBL] [Abstract][Full Text] [Related]
12. Numerical modeling of drug delivery in a dynamic solid tumor microvasculature.
Sefidgar M; Soltani M; Raahemifar K; Sadeghi M; Bazmara H; Bazargan M; Mousavi Naeenian M
Microvasc Res; 2015 May; 99():43-56. PubMed ID: 25724978
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric Imaging of Tumor Hypoxia and Perfusion with
Grkovski M; Schöder H; Lee NY; Carlin SD; Beattie BJ; Riaz N; Leeman JE; O'Donoghue JA; Humm JL
J Nucl Med; 2017 Jul; 58(7):1072-1080. PubMed ID: 28183993
[TBL] [Abstract][Full Text] [Related]
14. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.
Thorwarth D; Eschmann SM; Paulsen F; Alber M
Phys Med Biol; 2005 May; 50(10):2209-24. PubMed ID: 15876662
[TBL] [Abstract][Full Text] [Related]
15. Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Thorwarth D
Phys Med Biol; 2012 Mar; 57(6):1675-84. PubMed ID: 22398239
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.
Peeters SG; Zegers CM; Lieuwes NG; van Elmpt W; Eriksson J; van Dongen GA; Dubois L; Lambin P
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):351-9. PubMed ID: 25491505
[TBL] [Abstract][Full Text] [Related]
17. Image-based spatio-temporal model of drug delivery in a heterogeneous vasculature of a solid tumor - Computational approach.
Moradi Kashkooli F; Soltani M; Rezaeian M; Taatizadeh E; Hamedi MH
Microvasc Res; 2019 May; 123():111-124. PubMed ID: 30711547
[TBL] [Abstract][Full Text] [Related]
18. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic Analysis of Dynamic
Schwartz J; Grkovski M; Rimner A; Schöder H; Zanzonico PB; Carlin SD; Staton KD; Humm JL; Nehmeh SA
J Nucl Med; 2017 Jun; 58(6):911-919. PubMed ID: 28232611
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
Muzi M; Peterson LM; O'Sullivan JN; Fink JR; Rajendran JG; McLaughlin LJ; Muzi JP; Mankoff DA; Krohn KA
J Nucl Med; 2015 Aug; 56(8):1223-8. PubMed ID: 26112020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]